‘Major leap’: Test reduces unnecessary surgery for pancreatic cysts

A laboratory test that uses molecular and clinical markers, as well as machine learning, may help improve the management of pancreatic cysts and reduce unnecessary surgeries, according to data published in Science Translational Medicine.
One of the study authors, Christopher L. Wolfgang, MD, PhD, of the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins University, said that pancreatic cysts present a fundamental problem for treatment because most of them will never actually progress to cancer, but it is difficult to discern between low- and high-risk.
“We currently do not

Source link

Related posts

AIMS65 scoring system is comparable to Glasgow-Blatchford score or Rockall score for prediction of clinical outcomes for non-variceal upper gastrointestinal bleeding


An IL13Rα2 peptide exhibits therapeutic activity against metastatic colorectal cancer


Quantitative evidence for early metastatic seeding in colorectal cancer


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy